Login
Israel-Hamas Conflict
Rallies
Donald Trump
Boxing
World Cup
Social Media
Military
Baseball
Cryptocurrency
Soccer
Immigration
Juneteenth
Protestors
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

SGLT2 Inhibitors: From Glucose-Lowering to Cardio Protection

Summary by Medscape
Initially used for blood glucose control, the medications reduce cardiovascular events and mitigate heart failure hospitalization, regardless of diabetes status.

1 Articles

All
Left
Center
Right
MedscapeMedscape

SGLT2 Inhibitors: From Glucose-Lowering to Cardio Protection

Initially used for blood glucose control, the medications reduce cardiovascular events and mitigate heart failure hospitalization, regardless of diabetes status.

·United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Medscape broke the news in United States on Friday, June 13, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Medical

Medical

News
For You
SearchBlindspotLocal